Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allo-APZ2-CVU for chronic venous leg ulcers – randomized, double-blind, placebo-controlled phase IIb study
2020-004960-24Phase 2Active
- Sponsor
- RHEACELL
- Start
- Dec 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of EBESANAR in stasis ulcer (4 arms), sponsored by RHEACELL. Started Dec 2020; status: active.
02
Drugs
EBESANAR
03
Conditions
stasis ulcer
Beyond the preview
Go deeper on 2020-004960-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004960-24.